39th National Symposium
ANNA 2008 Satellite Symposium
What You Can Teach Your Team About
Chronic Kidney Disease-Related Mineral Bone Disorder (CKD-MBD).

Part One: The Increasing Prevalence of CKD
Rebecca Schmidt, DO, FACP, FASN and Sharon Senft, RN-C, FNP

Part Two: CKD and the Burden of Cardiovascular Disease
Sharon Senft, RN-C, FNP and Rebecca Schmidt, DO, FACP, FASN
Part Three: Early CKD-MBD Management as an Important Aspect of Improving Outcomes
Rebecca Schmidt, DO, FACP, FASN and Sharon Senft, RN-C, FNP
Panel Discussion
Rebecca Schmidt, DO, FACP, FASN; Sharon Senft, RN-C, FNP

At the conclusion of the certified activity, participants should be able to do the following:
Discuss the increasing prevalence of CKD
Review the high mortality rates in CKD
Identify CKD-MBD management as an important aspect of improving outcomes in CKD

Rebecca Schmidt, DO, FACP, FASN
West Virginia University School of Medicine
Mortantown, WV

Sharon Senft, RN-C, FNP
West Virginia University School of Medicine
Morgantown, WV
This activity has been planned and produced in accordance with CE guidelines and policies. From a CE symposium held in April 2008 at the American Nephrology Nurses' Association (ANNA) National Symposium in Philadelphia, PA.

This activity provides 1.25 contact hours.

The American Nephrology Nurses’ Association (ANNA) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is a Provider approved by the California Board of Registered Nursing, provider number CEP 00910 for 1.25 contact hours.

Posting Date: September 30, 2008
CE Credit Eligible Through: September 30, 2010
CE Credit Hours/Completion Time: 1.25
Target Audiences: Nurses, nurse practitioners, and technicians.
Method of participation: Listen to the talk, read the PubMed abstracts linked to data slides and talk references, take the post-test, read the linked abstracts in the post-test answer feedback material.
It is the policy of the American Nephrology Nurses' Association to insure balance, independence, objectivity, and scientific rigor in all its individual-sponsored or jointly sponsored educational programs. All faculty participating in any American Nephrology Nurses' Association sponsored programs are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships with commercial companies whose products or services may be mentioned so that listeners may form their own judgments about the presentation with the full disclosure of the facts. It remains for the audience to determine whether the speaker's outside interests may reflect a possible bias in either the exposition or the conclusions presented.

Rebecca Schmidt, DO, FACP, FASN, is a member of the Scientific Advisory Board for Genzyme Renal.

Sharon Senft, RN-C, FNP, is a member of the Speakers' Bureau for Genzyme Renal.

This ANNA Satellite symposium was developed by the ANNA, and supported by an unrestricted educational grant from Genzyme.

The CE policy and disclosure statements of the American Nephrology Nurses' Association are given in detail on the Symposium Home Page. The CE policy statements of HDCN are listed on this page.